Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Breast cancer (14)
- Cancer (14)
- Cilia (6)
- Doxorubicin (6)
- Primary cilia (6)
-
- Prostate cancer (6)
- Cytotoxicity (5)
- Adenylyl cyclase (4)
- Antiproliferative (4)
- Conformational Dynamics (4)
- Drug delivery (4)
- Proliferation (4)
- Resistance (4)
- SiRNA (4)
- Toxicity (4)
- Apoptosis (3)
- Brain (3)
- Cancer cells (3)
- Caveolae (3)
- Cell-penetrating peptide (3)
- Cellular uptake (3)
- Cilium (3)
- Cyclic peptide (3)
- Cyclic peptides (3)
- Deep learning (3)
- Drug discovery (3)
- Escherichia-Coli HSP90 (3)
- Exosome (3)
- Inflammation (3)
- Lipid rafts (3)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (128)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (29)
- Mathematics, Physics, and Computer Science Faculty Articles and Research (23)
- Student Scholar Symposium Abstracts and Posters (11)
- Health Sciences and Kinesiology Faculty Articles (10)
-
- Pharmaceutical Sciences (PhD) Dissertations (3)
- Engineering Faculty Articles and Research (1)
- Food Science (MS) Theses (1)
- Food Science Faculty Articles and Research (1)
- Library Articles and Research (1)
- Pharmaceutical Sciences (MS) Theses (1)
- Physical Therapy Faculty Articles and Research (1)
- Psychology Faculty Articles and Research (1)
- e-Research: A Journal of Undergraduate Work (1)
- Publication Type
Articles 211 - 212 of 212
Full-Text Articles in Life Sciences
Inhibition Of Cpla2-Mediated Arachidonic Acid Release By Cyclic Amp Defines A Negative Feedback Loop For P2y-Receptor Activation In Mdck-D1 Cells, Mingzhao Xing, Steven Post, Rennolds S. Ostrom, Michael Samardzija, Paul A. Insel
Inhibition Of Cpla2-Mediated Arachidonic Acid Release By Cyclic Amp Defines A Negative Feedback Loop For P2y-Receptor Activation In Mdck-D1 Cells, Mingzhao Xing, Steven Post, Rennolds S. Ostrom, Michael Samardzija, Paul A. Insel
Pharmacy Faculty Articles and Research
In Madin-Darby canine kidney D1cells extracellular nucleotides activate P2Y receptors that couple to several signal transduction pathways, including stimulation of multiple phospholipases and adenylyl cyclase. For one class of P2Y receptors, P2Y2 receptors, this stimulation of adenylyl cyclase and increase in cAMP occurs via the conversion of phospholipase A2 (PLA2)-generated arachidonic acid (AA) to prostaglandins (e.g. PGE2). These prostaglandins then stimulate adenylyl cyclase activity, presumably via activation of prostanoid receptors. In the current study we show that agents that increase cellular cAMP levels (including PGE2, forskolin, and the β-adrenergic agonist isoproterenol) can inhibit P2Y receptor-promoted AA release. The protein kinase …
Outpatient Administration Of Paclitaxel, Siu Fun Wong
Outpatient Administration Of Paclitaxel, Siu Fun Wong
Pharmacy Faculty Articles and Research
Paclitaxel (Taxol®, Bristol-Meyers Squibb), anti neoplastic agent made from the bark of the Pacific yew tree, is undoubtedly one of the most exciting agents to be evaluated over the past decade. Paclitaxel has demonstrated significant promise against ovarian and metastatic breast cancer, and appears to be the most effective single agent to date for non-small-cell lung cancer in trials conducted by Eastern Cooperative Oncology Group (ECOG).